Circle Pharma
Dr. Nikolovska-Coleska is an Associate Professor of Pathology, Director of the Molecular & Cellular Pathology Graduate Program at the University of Michigan and Associate Director of Program in Biomedical Sciences at University of Michigan. Her research group focuses on the discovery, design and development of new molecularly targeted therapies for cancer, particularly targeting protein-protein interactions that are involved in programmed cell death and epigenetic regulation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.